Pirtobrutinib in relapsed/refractory CLL/SLL: Results from BTK-naïve cohort in the phase 1/2 BRUIN study Meeting Abstract
| Authors: | Wierda, W. G.; Eyre, T. A.; Lech-Maranda, E.; Roeker, L. E.; Patel, M.; Fukuhara, N.; Woyach, J. A.; Brown, J. R.; Patel, K.; Tam, C. S.; Fahkri, B.; Abada, P.; Tsai, D. E.; Sizelove, R.; Jurczak, W. |
| Abstract Title: | Pirtobrutinib in relapsed/refractory CLL/SLL: Results from BTK-naïve cohort in the phase 1/2 BRUIN study |
| Meeting Title: | 12th Annual Meeting of the Society of Hematologic Oncology (SOHO 2024) |
| Keywords: | cll; chronic lymphocytic leukemia; relapsed/refractory; cancer; bruton tyrosine kinase inhibitors; (btki) |
| Journal Title: | Clinical Lymphoma, Myeloma and Leukemia |
| Volume: | 24 |
| Issue: | Suppl. 1 |
| Meeting Dates: | 2024 Sep 4-7 |
| Meeting Location: | Houston, TX |
| ISSN: | 2152-2650 |
| Publisher: | Elsevier Inc. |
| Date Published: | 2024-09-01 |
| Start Page: | S350 |
| Language: | English |
| ACCESSION: | WOS:001315579603104 |
| PROVIDER: | wos |
| DOI: | 10.1016/S2152-2650(24)01273-4 |
| Notes: | Meeting Abstract: CLL-269 -- Meeting was also available online -- Source: Wos |
